Samsung Biologics’ Public Offering for Rights Issue Proves a Hit, With Subscription Rate at 13,562%
- Input
- 2026-11-16 10:21:27
- Updated
- 2026-11-16 10:21:27

[Financial News] The public offering subscription for Samsung Biologics’ rights issue concluded with strong demand, recording a high subscription rate. Demand for the unsubscribed shares left after existing shareholders’ subscription topped 10,000%, pushing the overall subscription rate above 526%. According to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART) on the 16th, Samsung Biologics disclosed that it had received subscriptions for a total of 9,745,071 shares in the public offering held from the 12th to the 13th. The public offering comprised 71,854 unsubscribed shares, and the subscription rate reached 13,562.32%.
The planned number of shares to be issued in this rights offering is 2.27 million. Subscriptions were received for 405,430 shares through the employee stock ownership association and 1,762,046 shares through existing shareholders holding subscription rights certificates. Including an additional 30,670 shares subscribed for beyond their allotted amount, the total number of shares subscribed for was 2,198,146. The subscription rate among existing shareholders and the employee stock ownership association was 96.83%.
The process left 71,854 shares unsubscribed. Samsung Biologics conducted a public offering to allocate those shares.
The public offering drew subscriptions far exceeding the number of shares available. Subscriptions were received for 9,745,071 shares against an offering of 71,854 shares, resulting in a subscription ratio of 135.62 to 1 and a subscription rate of 13,562.32%.
The total number of shares subscribed for through the employee stock ownership association, existing shareholders, and the public offering was 11,943,217, based on a simple sum. The cumulative subscription rate against the planned issuance of 2.27 million shares was 526.13%.
Samsung Biologics also disclosed the upcoming schedule. The payment date for the subscription proceeds and the scheduled refund date are both the 17th, while the new shares are scheduled to be listed on the 30th of this month.
[email protected] Kang Jung-mo Reporter